BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10150367)

  • 1. Heart failure: clinical implications of recent trials.
    Pitt B; Nicklas JM
    Contemp Intern Med; 1994 Jun; 6(6):47-55. PubMed ID: 10150367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should three-drug therapy be standard for heart failure?
    Harv Heart Lett; 1999 Jan; 9(5):5-6. PubMed ID: 9916561
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG
    Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic therapy for heart failure.
    Stevenson LW
    N Engl J Med; 1998 Dec; 339(25):1848-50. PubMed ID: 9854124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern management of heart failure.
    Davies MK
    Br J Hosp Med; 1992 Jan 9-22; 47(1):16-8, 20-2, 24. PubMed ID: 1737187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential therapy of chronic heart failure].
    Riegger AJ
    Internist (Berl); 1993 Oct; 34(10):939-43. PubMed ID: 8225843
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical issues in the management of heart failure.
    Boccanelli A; Scardovi AB
    G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment guidelines for heart failure stress multidrug approach.
    Morey SS
    Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of heart failure secondary to coronary artery disease.
    Challapalli S; Bonow RO; Gheorghiade M
    Coron Artery Dis; 1998; 9(10):659-74. PubMed ID: 9894618
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics].
    Komajda M
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():13-6. PubMed ID: 10830083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is digoxin effective in the treatment of heart insufficiency in patients with sinus rhythm?].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 1999 May; 161(22):3269-74. PubMed ID: 10485204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of heart failure-relevant substance groups].
    Scholz H
    Verh Dtsch Ges Inn Med; 1990; 96():150-6. PubMed ID: 2092434
    [No Abstract]   [Full Text] [Related]  

  • 20. To dig or not to dig.
    Dagenais GR; Brophy JM
    Trans Am Clin Climatol Assoc; 1998; 109():51-61. PubMed ID: 9601127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.